Re:Nonprofit Working to Block Drug Imports Has Ties to Pharm...
by maxerickson on Tuesday April 18, 2017 @12:34PM
(#14140244)
Mylan has a patent on some minor improvement to Epipens. So it isn't just the FDA, they pushed generics off the market.
Mylan flat out admitted that costs aren't any more than $150 per pen when they launched a generic version of their own branded product. Everything above that is clearly them working to get as much price differentiation as possible.
Re:Nonprofit Working to Block Drug Imports Has Ties to Pharm...
by pc86 on Tuesday April 18, 2017 @12:46PM
(#14140390)
So why not sell Epipens without those minor, patented improvements for $20? Surely if there's profit to be made another provider would come in and destroy the $700 marginally better Epipen market.
Re:Nonprofit Working to Block Drug Imports Has Ties to Pharm...
by maxerickson on Tuesday April 18, 2017 @01:00PM
(#14140519)
I don't know why there weren't more competitors. Apparently part of it is that it is difficult to get right. Adrenaclick generics have been on the market much of that time for $150 or less.
One thing though, they would be epinephrine auto injectors, not Epipens, that's one of the things the patent did, it made it so that a prescription for Epipen could only be filled with Mylan's product.
So yes, the syringe and container themselves don't cost that much on a per unit basis (no clue but it's not nothing.) The regulatory costs are astronomical and have to be paid for over time. The general inanity of this stuff is mind boggling. The amount of paperwork insane.